Roberto Patuzzo

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

Veronica Huber, Viviana Vallacchi, Viktor Fleming et al. · Journal of Clinical Investigation · 2018 · 245 citations · Full text

Cancer Immunosurveillance, Mdsc Features, Mdsc Activity +14

Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study

Riccardo Danielli, Roberto Patuzzo, Anna Maria Di Giacomo et al. · Cancer Immunology Immunotherapy · 2015 · 173 citations · Full text

Medicine, Melanoma, Immunology +8

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

Lorenzo Pilla, Roberto Patuzzo, Licia Rivoltini et al. · Cancer Immunology Immunotherapy · 2005 · 137 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Phase Ii Trial +13

Sentinel and Nonsentinel Node Status in Stage IB and II Melanoma Patients: Two-Step Prognostic Indicators of Survival

Natale Cascinelli, Emilio Bombardieri, Rosaria Bufalino et al. · Journal of Clinical Oncology · 2006 · 133 citations · Full text

Prediction of Survival in Patients With Thin Melanoma: Results From a Multi-Institution Study

Andrea Maurichi, Rosalba Miceli, Tiziana Camerini et al. · Journal of Clinical Oncology · 2014 · 125 citations · Full text